Medical Hypotheses
Volume 51, Issue 6 , Pages 477-481, December 1998

Did consumption of flour bleached by the agene process contribute to the incidence of neurological disease?

  • C.A. Shaw

      Affiliations

    • Corresponding Author InformationCorrespondence to: C.A. Shaw PhD, c/o Department of Anatomy, 2177 Wesbrook Mall, University of British Columbia, Vancouver, BC, Canada, V6T 1Z3 (Phone: +1 604 822 6612, Fax: +1 604-822-2316)
  • ,
  • J.S. Bains

Department of Ophthalmology, c/o Department of Anatomy, University of British Columbia, Vancouver, British Columbia, Canada

Received 3 February 1998; accepted 13 May 1998.

Abstract 

The present report proposes the hypothesis that increased levels of neurodegenerative disorders in humans may have arisen due to inclusion in the diet of methionine sulfoximine (MSO), a byproduct of the bleaching of flour by nitrogen trichloride. This method of bleaching, the ‘agene process’ was in use from early in the century and continued until at least 1949/1950. Estimates indicate that, at least in the UK, as much as 80% of all flour during this period was produced by this process. MSO acts directly to inhibit the production of two crucial molecules, glutathione (GSH) and glutamine. Decreases in GSH, a key antioxidant and free radical scavenger, diminish the body's antioxidant defenses and may lead to increased oxidative stress. Decreases in glutamine synthesis may act to increase free glutamate and give rise to increased levels of ammonia. Cells in the nervous system are particularly sensitive to a decline in either GSH or glutamine. The combined effects of decreases in these molecules, particularly with long-term exposure to MSO in bleached flour, may have had quite drastic effects on neuronal health and survival. The present hypothesis may provide clues to the etiology of neurological disorders such as Alzheimer's disease (AD), Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS), suggesting that such disorders may arise in part due to toxic actions of some compounds in processed human foods.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by the ALS Association

PII: S0306-9877(98)90067-6

Medical Hypotheses
Volume 51, Issue 6 , Pages 477-481, December 1998